Garcia-Reyes K, et al. - This research coveted an investigation of the effect of lesion visibility with transrectal ultrasound (TRUS) on the prediction of clinically significant prostate cancer (CS-PCA) with TRUS-magnetic resonance imaging (MRI) fusion biopsy. The results deduced that the lesion visibility on MRI or TRUS signified a similar probability of CS-PCA. This probability appeared to be greater when both exams were positive.